Tag: CIRSE
ASPCVIR president-elect provides a glimpse into IR in the Asia-Pacific region
Born and raised in Singapore, interventional radiologist Tay Kiang Hiong is professor and head of the department of vascular and interventional radiology at Singapore...
CIRSE Clinical Practice Survey: Patient safety and quality improvement in IR
Andreas Mahnken (University Hospital Marburg, Marburg, Germany), distinguished interventional oncologist, educator and advocator for interventional radiology (IR) standardisation, dives into the most salient outcomes...
Interventional News Issue 96—November 2024 US Edition
Interventional News 96 Highlights:
New research finds that genicular artery embolization (GAE) has a lasting benefit of up to two years for moderate to...
Interventional News Issue 96—November 2024 Edition
Interventional News 96 Highlights:
New research finds that genicular artery embolization (GAE) has a lasting benefit of up to two years for moderate to...
Real-world registry shows sustained efficacy for Eluvia DES in the SFA
This advertorial is sponsored by Boston Scientific.
During a satellite symposium session dedicated to real cases and trial outcomes which was held at the Cardiovascular...
Has interventional radiology reached its global tipping point?
In a new global statement, aimed to set forth the essential elements of interventional radiology (IR) and continuing challenges facing the specialty, the Cardiovascular...
WAVE trial reports Wrapsody superiority over standard PTA
Six-month results of the WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal trial have reported superior target lesion primary patency (TLPP) with Wrapsody (Merit Medical) cell-impermeable...
“Game-changing” six-month SUCCESS PTA results report Selution SLR efficacy
The first report of six-month results from the SUCCESS PTA trial evaluating the Selution SLR (Cordis) drug-eluting balloon has shown that consistent haemodynamic, functional...
Merit Medical’s Wrapsody WAVE trial demonstrates superior patency versus standard of...
Merit Medical has today announced positive six-month findings from the randomised arteriovenous (AV) fistula arm of its Wrapsody Arteriovenous Access Efficacy (WAVE) pivotal trial....
CIRSE launch immuno-oncology trial alongside Immunophotonics
Immunophotonics has announced a collaboration with The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) around a phase 2/3 clinical trial.
The trial is designed...
Minimal IR “survival kit”: What you need to know about trauma...
“When providing a 24/7 interventional radiology trauma service, sometimes our procedures are expected to be concluded in few minutes. That’s why it’s important...
Get what you want from your career: CIRSE Women in IR...
Taking place at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual congress (14–18 September, Lisbon, Portugal) the Women in Interventional Radiology...
Miyuki Sone spotlights women’s empathy as crucial part of any IR...
“It’s a boy’s club. If the only examples of success are men, it becomes harder for women to envision themselves in those positions.” These...
Patrick Haage
As a champion of innovation and forward movement in his chosen field of interventional radiology (IR), Patrick Haage’s career is no less a reflection...
Interventional News Issue 95—August 2024 US Edition
Interventional News 95 Highlights:
Findings from a post-hoc analysis of Lutonix arteriovenous (AV) global registry data
Interview with Philip Dombrowski (Cape Cod Hospital, Hyannis,...
Interventional News Issue 95—August 2024 Edition
Interventional News 95 Highlights:
Findings from a post-hoc analysis of Lutonix arteriovenous (AV) global registry data
Interview with Philip Dombrowski (Cape Cod Hospital, Hyannis,...
CIRSE begins CALCIO trial enrolment for treatment of CLTI with Shockwave...
The Cardiovascular and Interventional Society of Europe (CIRSE) have announced that patient enrolment for the CALCIO trial has begun. CALCIO started patient enrolment on...
First release #HOPE4LIVER data reveals “exciting” potential of histotripsy for liver...
Clinical professor of radiology Mishal Mendiratta-Lala (Michigan, USA), expands on the first data release from the #HOPE4LIVER trial, presented during the FIRST@CIRSE session at...
Paediatric interventional radiologists call for intended-for-use device development
Lagging behind the rapid advancements within the speciality as a whole, a 2023 study titled ‘Is there really no kit for kids?’ has identified...
You can’t always get what you want, but you may get...
Over several decades, interventional radiology (IR) has scaled to significant heights, leading technological advancements and minimally-invasive techniques. As these milestones have been reached, however,...
Interventional News welcomes new editor-in-chief Robert Morgan
Interventional News is delighted to welcome professor of interventional radiology Robert Morgan (St George’s Hospital NHS Foundation Trust, London, UK) as editor-in-chief. Morgan is...
Interventional News Issue 92—November 2023 US Edition
Interventional News 92 Highlights:
International IR voices map the path to primary specialty
Interventional News welcomes new editor-in-chief Robert Morgan
Profile: Jonathan Moss
CIRSE: Top...
Interventional News Issue 92—November 2023
Interventional News 92 Highlights:
International IR voices map the path to primary specialty
Interventional News welcomes new editor-in-chief Robert Morgan
Profile: Jonathan Moss
CIRSE: Top...
Thyroid thermal ablation “comes of age” internationally
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2023 annual meeting (9–13 September, Copenhagen, Denmark) saw presenters explore where thyroid thermal ablation treatments...
Five-year RCT data provide upbeat message on Luminor paclitaxel-coated balloon’s safety...
NOTE: This video is ONLY available to watch in selected countries and geographies
The EffPac trial was a prospective, multicentre, randomised controlled trial (RCT)...
VOLA II trial results to ‘change practice’ and ‘improve outcomes’
“We wanted to find a common language between interventional radiologists and nephrologists and we wanted to be sure that the angioplasty we have done...
“Excellent” 24-month MOTIV BTK outcomes for bioresorbable scaffold use in below-the-knee...
Presenting data from the MOTIV bioresorbable scaffold (Reva Medical) below-the-knee (BTK) trial during Saturday’s FIRST@CIRSE session at this year’s Cardiovascular and Interventional Radiological Society...
CIRSE radiation protection sessions address geographical disparities and mitigation of perceived...
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2023 annual meeting (9–13 September, Copenhagen, Denmark) hosted sessions dedicated to radiation protection, contemporary risk...
12-month PRISTINE registry data show efficacy of sirolimus-eluting balloon in the...
Tze Tec Chong (Singapore General Hospital, Singapore) presented results from the PRISTINE registry at this year’s Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2023...
IR is a therapeutic field and “we want to focus on...
Christoph Binkert (Winterthur, Switzerland) and current president of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) tells Interventional News about the three-fold focus...
Specialty status “crucial” to give IR control over training future generations
Raman Uberoi (Oxford, UK), who delivered this year’s Andreas Gruentzig Lecture at the CIRSE annual meeting told Interventional News: “We need to radically think about how...
CIRSE curriculum update targets greater harmonisation and improvement in global IR...
In February 2023, the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), in conjunction with the European Union of Medical Specialists (UEMS) Interventional Radiology...
Interventional News’ top 10 most popular stories of July 2023
Interventional News’ most popular stories from July included point of view pieces from interventional radiologists on fallopian tube recanalisation and interventions for postpartum haemorrhage,...
CIRSE supports use of paclitaxel-coated devices in femoropopliteal disease treatment
In June 2023, the Cardiovascular Interventional Radiological Society of Europe (CIRSE) published an editorial in Cardiovascular Interventional Radiology (CVIR). Written on behalf of CIRSE’s...
IR treatments for postpartum haemorrhage “still significantly underutilised”
The Cardiovascular Interventional Radiological Society of Europe (CIRSE) 2020 Standards of Practice document for gynaecological and obstetric haemorrhage are among the most comprehensive guidelines...
Real-world data consistent with RCTs in highlighting the efficacy of drug-eluting...
This advertorial is sponsored by Boston Scientific.
During a recent satellite symposium, which took place at the 2022 Cardiovascular Interventional Radiological Society of Europe (CIRSE)...
Interventional News’ top 10 most popular stories of November 2022
Interventional News’ most popular stories last month included news of a US Food and Drug Administration pre-market approval submission of an ultrasound renal denervation...
“Put ego aside” to keep patient outcome the priority during multidisciplinary...
“If it were easy, this session would not be here.” These are the words of Jens Ricke (University Hospital Munich, Munich, Germany), who drew...
Dimitrios Filippiadis
“The spine is an area where interventional radiologists play a crucial role in both diagnosis and therapeutic management of a variety of pathologies”.
Dimitrios...
Josef Roesch Lecture incites and evidences interest in growing paediatric IR...
Paediatric interventional radiologist Alex Barnacle (Great Ormond Street Hospital, London, UK) gave the Josef Roesch Lecture at the Cardiovascular and Interventional Radiological Society of...
SAVAL trial finds no gains with custom drug-eluting stents in PAD...
Day one of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting (10–14 September, Barcelona, Spain) put a strong focus on...
38th CIRSE annual congress begins this weekend
The European Society of Cardiovascular and Interventional Radiology (CIRSE) will host its 38th annual meeting in Barcelona from September 10 until September 14. Around...
Philips gives updates on spectral detector angio CT solution development
Royal Philips today announced new milestones in the development of the world’s first spectral detector angio computed tomography (CT) solution— Philips Spectral Angio CT...
“An important pillar of tumour treatment”: Degradable starch microspheres accepted by...
This advertorial is sponsored by PharmaCept.
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) recently incorporated transarterial chemoembolization with degradable starch microspheres (DSM-TACE) into...
“Very encouraging” 12-month data from WRAPSODY FIRST study presented at CIRSE...
Twelve-month results from a first-in-human study of the Wrapsody cell-impermeable endoprosthesis (Merit Medical Systems) for the treatment of access circuit stenosis in haemodialysis patients...
Wesley Medical Imaging becomes first hospital in Australia to achieve IASIOS...
Ten centres have achieved the International Accreditation System for Interventional Oncology Services (IASIOS) accreditation, a benchmark of quality standard and assurance, since 2018. Wesley...
IASIOS, the world’s first accreditation programme for interventional oncology, just opened...
The International Accreditation System for Interventional Oncology Services (IASIOS) has passed its pilot phase with flying colours, the Cardiovascular and Interventional Radiological Society of...
First fully remote, online-proctored EBIR examination takes place
The first fully remote, online-proctored European Board of Interventional Radiology (EBIR) examination took place on 13 January, 2021, with a 113 participants from 25...
The largest European cohort on the treatment of liver cancer with...
The largest European-wide observational study on the treatment of primary and metastatic liver tumours with SIR-Spheres microspheres (Sirtex) will present its data on safety...
ECIO 2020 “will not take place as a physical meeting”
The European Conference on Interventional Oncology (ECIO), hosted by the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) have announced that their November meeting...
The first virtual CIRSE: What you need to know
Ahead of the first ever virtual meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), Thomas Kröncke, chairperson of the CIRSE 2020...
“Significant heterogeneity” in IR training across Europe
The European Trainee Forum (ETF) Subcommittee of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has published a report on the status of...
Letter to CVIR Editor calls for “further European-wide initiatives” to establish...
Despite being “perfectly placed” to help meet the increasing demand for stroke thrombectomy, there is not an established training structure for interventional radiologists wishing...
CIRSE president: “We need more of a European focus” to protect...
“Europe, including the European Union (EU) and the leaders of its nation states, needs to prepare better for future pandemics. I think we must...
Seven CIRSE Academy courses currently free to access
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has made seven of ts Academy courses free to access online.
On its website, the...
International accreditation scheme “brings IO into the mainstream”
The newly established International Accreditation System for Interventional Oncology Services (IASIOS) gives medical facilities the opportunity to receive credentials for their interventional oncology (IO)...
CIRSE and APSCVIR publish checklist for preparing your IR service for...
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) and the Asia Pacific Society of Cardiovascular and Interventional Radiology (APSCVIR) have jointly published a...
Experts discuss latest results from EFFPAC and TINTIN trials presented at...
NOTE: ONLY intended for healthcare professionals outside of the USA.
Ulf Teichgräber (Jena, Germany) and Koen Deloose (Dendermonde, Belgium) discuss the 24-month results of the...
CIRSE updates and expands their interventional radiology curriculum for medical students
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has released a newly revised interventional radiology (IR) curriculum for medical students. Where the original...
CIRSE updates position on paclitaxel use in peripheral arteries
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has released a statement on the use of paclitaxel-coated balloons and stents in the treatment...
Stem cell therapy is the future of critical limb ischaemia management
Addressing the audience at the 33rd annual meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE; 22–25 September, Lisbon, Portugal), Sanjiv Sharma...
Leading interventional radiology societies call for expanded stroke training
In a joint, global position statement, the Society of Interventional Radiology (SIR), Cardiovascular and Interventional Radiology Society of Europe (CIRSE) and the Interventional Radiology...
A “mediocre success rate” found for coil embolization to obtain intrahepatic...
Coil embolization of hepatic arteries to induce redistribution of blood flow and microspheres has a mediocre success rate, concluded a recent study presented by...
Lessons from randomised controlled trials utilising SIRT in liver cancer
A recent session at CIRSE 2018 sought to go beyond the headline findings from a number of recent randomised controlled trials (RCTs) in interventional...
Interim results of the Lutonix drug-coated balloon in a complex patient...
This article is sponsored by BD.
In a complex patient population with advanced, symptomatic below-the-knee peripheral artery disease, treatment with the Lutonix drug-coated balloon (BD)...
Covered stent provides greater patency than angioplasty alone in AV fistulae
The Covera vascular covered stent (BD) has a superior six-month primary patency rate than standard balloon angioplasty, with an equivalent safety at 30 days,...
Real-time imaging: Ultrasound detects a biodegradable embolic microsphere after prostatic artery...
Researchers report the use of ultrasound to detect embolization in real time for patients undergoing treatment for benign prostatic hyperplasia (BPH). Richard Owen (University...
Eluvia outperforms Zilver PTX in IMPERIAL 12-month results
The Eluvia drug-eluting vascular stent system (Boston Scientific) shows superior primary patency compared to the Zilver PTX drug-eluting stent (Cook Medical), concludes the 12-month...
ICEfx cryoablation system launches globally at CIRSE 2018
BTG has announced the global launch of its ICEfx cryoablation system. This is an evolution of the existing Visual ICE system, and according to...
First patient enrolled in CIREL, a Europe-wide observational study on TACE...
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) announced that the first patient has been enrolled in CIREL (CIRSE registry for LifePearl microspheres),...
Cook Medical’s inferior vena cava filters fare better than ALN’s in...
Gerard Goh, Radiology, The Alfred Hospital, Melbourne, Australia, reported results from a comparative study of inferior vena cava (IVC) filters at CIRSE 2017 that...
Eluvia paclitaxel-eluting stent shows long-term freedom from revascularisation at three years
Boston Scientific has announced the three-year results from the MAJESTIC trial for the Eluvia paclitaxel-eluting vascular stent system at the Cardiovascular and Interventional Radiological...
Terumo launches QuiremSpheres microspheres in Europe
Terumo has announced that it has launched QuiremSpheres microspheres in Europe on 18 September.
QuiremSpheres, the next generation of selective internal radiation therapy (SIRT) microspheres...
Luminor DCB shows high clinical effectiveness in six-month EffPAC data
The six-month results from the full clinical cohort of the EffPAC randomised study were presented in the drug-coated balloon (DCB) abstracts session at the...
Guerbet announces CE mark for Vectorio mixing and injection system for...
Guerbet has announced obtaining the CE mark for its conventional transarterial chemoembolization (cTACE) mixing and injection system, Vectorio.
Designed in collaboration with interventional radiologists worldwide,...
CIRSE launches new journal—CVIR Endovascular
Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has announced the start of a new journal, CVIR Endovascular, which will be an offshoot of...
Mentice aims to reduce TACE procedure times and radiation exposure with...
Mentice has announced the release of a new simulation training software for transarterial chemoembolization (TACE). The new software was showcased at the 2017 CIRSE...
Update for CIRSE’s European IR Curriculum and Syllabus
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has announced the presentation of the second edition of the European Curriculum and Syllabus for...
CIRA appoints Daniel Lapointe as new executive director
The Canadian Interventional Radiology Association (CIRA) Board of Directors has announced the appointment of Daniel Lapointe as CIRA’s new executive director on the association’s...
CIRSE launches Europe-wide study of transarterial chemoembolization with Terumo Lifepearl
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has launched its CIRSE Registry for LifePearl Microspheres (CIREL), a new European-wide observational study that...
The ESR and CIRSE join forces to promote patient care
The European Society of Radiology (ESR) and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), have joined forces to address the future of...
Irreversible electroporation has “potential to become new standard of care” in...
A new study presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE 2016, 10–14 September, Barcelona, Spain) meeting finds that the treatment...
